Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up

Although both angiotensin receptor blockers (ARBs) and dihydropyridine calcium channel blockers (CCBs) are all suitable for the initiation of antihypertensive treatment, studies investigating efficacy and safety between ARBs and CCBs are limited, and there is no previous study comparing their clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Han Saem, Lim, Hong‐Seok, Park, Hun-Jun, Lee, Wang-Soo, Choi, Jin-Oh, Lee, Hui Seung, Jo, Sang-Ho, Hong, Soon Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815918/
https://www.ncbi.nlm.nih.gov/pubmed/33469103
http://dx.doi.org/10.1038/s41598-021-81373-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815918/
https://www.ncbi.nlm.nih.gov/pubmed/33469103
http://dx.doi.org/10.1038/s41598-021-81373-7

Ejemplares similares